Medical News

RSS

Complex issue of CER in biopharmaceutical development explored

In a new report released today, John Doyle, Vice President and Practice Leader for Quintiles Consulting, and an expert on pharmaceutical market access, explores the complex issue of comparative effectiveness research (CER) and its strategic importance in successful and efficient biopharmaceutical development.

22 Oct 2009

Pregnant women who are lesbians are not receiving the same care as other mothers-to-be: Study

Midwives often struggle to meet the needs of pregnant women who are lesbians, with patients reporting that the focus is often on their sexuality rather than the fact that they are expecting a baby, according to research in the November issue of the Journal of Advanced Nursing.

22 Oct 2009

New study on the factors that determine development of posttraumatic stress disorder

After exposure to extreme life stresses, what distinguishes the individuals who do and do not develop posttraumatic stress disorder (PTSD)? A new study, published in the October 1st issue of Biological Psychiatry, suggests that it has something to do with the way that we control the activity of the prefrontal cortex, a brain region thought to orchestrate our thoughts and actions.

22 Oct 2009

Scientists explore new molecular insights for treating anxiety disorders

There are increasingly precise molecular insights into ways that stress exposure leads to fear and through which fear extinction resolves these fear states. Extinction is generally regarded as new inhibitory learning, but where the inhibition originates from remains to be determined.

22 Oct 2009

Precise Biometrics: Interim report January – September 2009

Precise Biometrics AB, Corporate Identity No 556545-6596 Interim report for the period January – September 2009

22 Oct 2009

Healthcare organizations meet at the third Annual Integrated Provider Management Symposium

More than 28 healthcare organizations were represented at the third Annual Integrated Provider Management (IPM) Symposium, hosted by Portico Systems. The focus of the event was how health plans are preparing for industry changes in terms of access, quality and payment reform.

22 Oct 2009

Fluoride content in infant formulas can cause tooth discoloration

All infant formulas, whether ready-to-feed, concentrated or organic, contain fluoride at levels which can discolor developing teeth, reports the October 2009 Journal of the American Dental Association (JADA)(1).

22 Oct 2009

Medical Marijuana commences multi-industry implementation of its tax remittance solution

Medical Marijuana Inc has entered into discussions with a publicly traded coffee distribution company for licensing of its patent pending tax remittance solution. Medical Marijuana Inc's tax remittance technology was originally designed to be industry and product neutral; it can be implemented in any industry.

22 Oct 2009

18 Los Angeles residents charged in five indictments for allegedly participating in Medicare fraud schemes

Eighteen defendants, most of them residing in the Los Angeles area, have been charged in five indictments for allegedly participating in Medicare fraud schemes that resulted in approximately $25 million in fraudulent bills to the Medicare program, announced Assistant Attorney General of the Criminal Division Lanny A. Breuer, Acting U.S. Attorney for the Central District of California George S. Cardona and Daniel R. Levinson, Inspector General of the Department of Health & Human Services (HHS).

22 Oct 2009

LANL and international researchers propose new genome sequence strategies

A team of geneticists at Los Alamos National Laboratory, together with a consortium of international researchers, has recently proposed a set of standards designed to elucidate the quality of publicly available genetic sequencing information.

22 Oct 2009

Update from Karo Bio for the period January-September

In an update of the project portfolio, Karo Bio announced, among other things, that the company, in accordance with earlier communicated plans, has submitted an IND application for eprotirome to the American Food and Drug Administration (FDA); that a candidate drug has been nominated within the ER-beta program; and that the company has decided not to initiate further in-house development of KB3305 for the treatment of type 2 diabetes.

22 Oct 2009

SAGE announces the launch of "Therapeutic Advances in Musculoskeletal Disease"

SAGE has announced the launch of Therapeutic Advances in Musculoskeletal Disease, the latest in SAGE's highly-regarded Therapeutic Advances series.

22 Oct 2009

SAEC to collaborate with HMORN to improve the safe use of drugs

The International Serious Adverse Events Consortium (SAEC) announced today it will collaborate with the HMO Research Network (HMORN) to improve the safe use of drugs by exploring why the genetic makeup of some individuals makes them more likely to experience serious drug-related adverse events (SAEs).

22 Oct 2009

Researchers develop a new test process for cancer drugs

It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs.

22 Oct 2009

Clinical performance study reveals the accuracy and precision of TRUE2go system

Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, “Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips,” demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.

22 Oct 2009

Industries oppose proposed assisted living regulations

With Pennsylvania just weeks away from the publication of final assisted living regulations, recently-released survey results about the size of living units in existing facilities show the wisdom of the proposed rules -- and the absurdity of the industry's opposition.

22 Oct 2009

Sosei Group announces Phase III trials update on NVA237 and QVA149

Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that the Phase III trials with NVA237, which commenced in June 2009, are proceeding to plan. Initiation of Phase III studies with QVA149 is now expected to occur during 2010.

22 Oct 2009

Web-savvy johns use the Internet to warn of prostitution hot zones and stings, Study finds

The Internet has spawned a virtual subculture of "johns" who share information electronically about prostitution, potentially making them harder to catch, according to a new study co-authored by a Michigan State University criminologist.

22 Oct 2009

Plant-based foods could help fight obesity and heart disease

The cheeseburger and French fries might look tempting, but eating a serving of broccoli or leafy greens first could help people battle metabolic processes that lead to obesity and heart disease, a new University of Florida study shows.

22 Oct 2009

SNAP Diagnostics joins SAFE-BioPharma Association

SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.

22 Oct 2009